Admission Date:  [**2182-6-12**]              Discharge Date:   [**2182-6-22**]  Date of Birth:  [**2128-11-12**]             Sex:   M  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 2297**] Chief Complaint: dyspnea   Major Surgical or Invasive Procedure: CT guided needle biopsy Intubation Arterial cannulation, a-line placement Central line placement  History of Present Illness: Pt is a 53 Y M with Hx of DM2, HTN who is transferred from [**Hospital3 **] after being hospitalized from [**6-5**] - [**6-12**] with bilateral pneumonia and concern for new malignancy.
2 weeks prior to admission to the OSH, he was experiencing cold-like symptoms and received Azithromycin without relief.
On [**6-5**] he started Ceftriaxone, Azithromycin, and IV steroids for supposed concurrent COPD exacerbation.
He could not tolerate BiPAP and was given nasal O2.
Denies nausea, vomiting, diarrhea, constipation, abdominal pain, melena, hematemesis, hematochezia.
Past Medical History: PMH: Bilateral PNA DM2 on Metformin HTN Hyponatremia Atypical chest pain with a normal stress test in [**2179**] Hyperlipidemia Asthma as a child OSA Seasonal allergies  Social History: Works in IT.
Father with CABG x4 in his 60s.
Physical Exam: ADMISSION EXAM VS: T 97.4  bp 144/90  HR 98  RR 18  SaO2 93% on 3L NC RR 18 GEN: NAD, awake, alert HEENT: EOMI, sclera anicteric, conjunctivae clear, OP moist and without lesion, PERRLA at 3mm NECK: Supple, cannot appreciate JVD CV: Reg rate, normal S1, S2.
For example, right anterior mediastinal node measuring 1.5 x 1.5 cm, previously measured 1.6 x 1.4 cm (4:11); 2.2 x 1.2 cm right precarinal node (4:20), previously measured 1.2 x 2.3 cm; more inferiorly, 2.5 x 1.9 cm node (4:23), previously was 2.5 x 2.0 cm.
Right paraesophageal nodal conglomerate  is unchanged and measures 4.9 x 3.7 cm (4:33).
For example, right retroperitoneal node measuring 1.7 x 2.8 cm (4:63), previously measured 1.4 x 2.7 cm on the prior study; epigastric node measuring 1.8 cm, is similar to the prior study (4:57); left paraaortic nodal conglomerate measures 3.2 x 2.3 cm compared to 3.2 x 2.1 cm on the prior study.
Calretinin appears to stain tumor cells (patchy) and mesothelial cells.
On [**6-5**] he started Ceftriaxone, Azithromycin, and IV steroids for supposed concurrent COPD exacerbation.
His oxygen demand was initially 3L on nasal cannula with saturation in the 90's.
This gradually worsened to 6L on NC to 6L NC plus shovel mask with saturation maintaining 90-95%.
He is on IV heparin for this with goal PTT of 50-70 to avoid bleeding.
on [**2182-6-19**] CXR was suggestive of superimposed pneumonia (vanc and zosyn were started for nosocomial pneumonia on that day) in addition to underlying pulmonary metastases and new mild pulmonary edema.
VS on the floor prior to MICU transfer were: Afebrile, Saturating mid-high 80's to low 90's on nasal cannula and shovel mask sitting in chair and looking exhausted with the head bowed down.
He was put on face mask ventilation but continued to have increased work of breathing and worsening respiratory status.
Femoral line and a-line were placed.
Patient suspected to be in pneumosepsis, and became hypotensive and required pressor support with levophed and vasopressin.
Continuing hypotension required additional support with phenylephrine.
Medications on Admission: Preadmission medications listed are correct and complete.
Atorvastatin 80 mg PO HS 4.
Lisinopril 30 mg PO DAILY 5.
Omeprazole 20 mg PO DAILY 6.
Chlorthalidone 12.5 mg PO DAILY 7.
MetFORMIN (Glucophage) 1000 mg PO BID 8.
Aspirin 81 mg PO DAILY   Discharge Medications: N/A  Discharge Disposition: Expired  Discharge Diagnosis: Cardiopulmonary arrest  Discharge Condition: Expired  Discharge Instructions: N/A  Followup Instructions: N/A   Completed by:[**2182-6-24**
